Xcout Intel
NEURONA THERAPEUTICS INC competitors & alternatives
The 12 closest competitors and alternatives to NEURONA THERAPEUTICS INC among biotechnology companies — ranked by similarity to what NEURONA THERAPEUTICS INC actually does, not by market-cap band.
Subscribe to see NEURONA THERAPEUTICS INC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About NEURONA THERAPEUTICS INC
Neurona Therapeutics Inc. is a biotherapeutics company that focuses on developing cell-based therapies to address neurological disorders.
NEURONA THERAPEUTICS INC at a glance
NEURONA THERAPEUTICS INC is a biotechnology company headquartered in United States. Its most recent funding round raised $102M in April 2025. Xcout tracks 9 named people at NEURONA THERAPEUTICS INC, including James Stutz (Chief Financial Officer).
NEURONA THERAPEUTICS INC leadership
- James StutzChief Financial Officer
- Cory R. NicholasChief Executive Officer and Co-Founder
- Cory NicholasExecutive Officer
- James StutzExecutive Officer
- Brad MargusDirector
- Erica WhittakerDirector
3 more named people on record for NEURONA THERAPEUTICS INC, with roles, board committees and tenure — see the full roster →
NEURONA THERAPEUTICS INC funding rounds
The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $102M | 13 named | |
| SEC Form D filing | $120M | — | |
| — | $120M | — | |
| SEC Form D filing | $72M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent NEURONA THERAPEUTICS INC news
Top 12 NEURONA THERAPEUTICS INC competitors
Ranked by semantic similarity — how close each company is to NEURONA THERAPEUTICS INC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Neuron23 is a biotechnology company founded in 2018 that focuses on developing precision therapeutics for genetic diseases. Headquartered in South San Francisco, California, the company relies on a team of scientific experts and entrepreneurs.
Biotech
Neumora Therapeutics is a clinical-stage biopharmaceutical company developing precision medicines for brain diseases, including neuropsychiatric and neurodegenerative disorders. It uses neuroscience, data science, and biomarkers to identify and advance treatments for patients with these conditions.
Similar biotechnology company
Novoron Bioscience, Inc. is a San Diego-based biotechnology company developing novel therapeutics to address central nervous system and other conditions.
Similar biotechnology company
Asceneuron is a biotechnology research company founded in 2012 and headquartered in Eysins, Switzerland, focusing on the discovery and development of therapeutics for neurodegenerative disorders.
Similar biotechnology company
Aspen Neuroscience, Inc. is a clinical-stage private biotechnology company headquartered in San Diego, California. The company focuses on developing personalized autologous cell therapies for neurodegenerative diseases.
Similar biotechnology company
Argo Therapeutics is a Swiss biotechnology company headquartered in Allschwil, Switzerland, focused on neurodegenerative-disease therapeutics.
Life Sciences
Cajal Neuroscience (Cajal Therapeutics Inc.) is a biotechnology company headquartered in Seattle, Washington. The company is dedicated to advancing therapeutic pipelines in neuroscience research.
Similar biotechnology company
Muna Therapeutics is a privately held biopharmaceutical company founded in 2020 with headquarters in Copenhagen, Denmark, and operations in Leuven. The company discovers and develops novel therapies aimed at slowing or stopping devastating neurodegenerative diseases like Alzheimer's and Parkinson's.
Biotech
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Biotech
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
Similar biotechnology company
Arkuda Therapeutics is a biotechnology company developing small-molecule treatments for neurodegenerative diseases, with a focus on restoring lysosomal function and addressing progranulin-related disease biology. Its programs are aimed particularly at patients with frontotemporal dementia and other disorders involving lysosomal dysfunction.
Similar biotechnology company
Amygdala Neurosciences Inc is an independent small biopharmaceutical company headquartered in San Francisco, California. Its mission is to invent and develop first-in-class therapeutics.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of NEURONA THERAPEUTICS INC and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for NEURONA THERAPEUTICS INCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →